almonertinib   Click here for help

GtoPdb Ligand ID: 11136

Synonyms: Ameile | Egfr T790M inhibitor HS-10296 | example 26 [WO2016054987A1] | HS10296
Approved drug
almonertinib is an approved drug (China (2020))
Compound class: Synthetic organic
Comment: Almonertinib (HS-10296) is an orally bioavailable, third generation inhibitor of the receptor tyrosine kinase epidermal growth factor receptor (EGFR) with activity at the EGFRT790M mutant [1]. In assays using triple-negative breast cancer MDA-MB-231 cells, HS-10296 inhibits signalling via the EGFR/PI3K/AKT pathway which results in reduced proliferation and induction of autophagy and apoptosis. HS-10296 was developed by Hansoh Pharmaceutical, and ex-China rights were licensed to EQRx in mid-2020.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 12
Topological polar surface area 87.55
Molecular weight 525.29
XLogP 4.14
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES C=CC(=O)Nc1cc(Nc2nccc(n2)c2cn(c3c2cccc3)C2CC2)c(cc1N(CCN(C)C)C)OC
Isomeric SMILES C=CC(=O)Nc1cc(Nc2nccc(n2)c2cn(c3c2cccc3)C2CC2)c(cc1N(CCN(C)C)C)OC
InChI InChI=1S/C30H35N7O2/c1-6-29(38)32-24-17-25(28(39-5)18-27(24)36(4)16-15-35(2)3)34-30-31-14-13-23(33-30)22-19-37(20-11-12-20)26-10-8-7-9-21(22)26/h6-10,13-14,17-20H,1,11-12,15-16H2,2-5H3,(H,32,38)(H,31,33,34)
Bioactivity Comments
HS-10296 inhibits EGFRT790M enzyme activity in a TR-FRET assay with an IC50 of 0.49 nM (compared to an IC50 of 1.89 nM for wild type enzyme) [1].
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
epidermal growth factor receptor Hs Inhibitor Inhibition 8.7 pIC50 - 1
pIC50 8.7 (IC50 1.89x10-9 M) [1]
Description: Inhibition of wild type EGFR enzyme activity in a TR-FRET assay